Mediner

What Mediner does

Mediner Kft. is a privately held Hungarian pharmaceutical distribution company founded in 2000 and headquartered in Debrecen. The company acquires drug licenses from European pharmaceutical manufacturers and distributes their products through wholesale channels to healthcare providers and pharmacies across Hungary. It concentrates its commercial activity in three specialist therapeutic areas: dermatology, pulmonology, and gynecology. Its flagship branded product is LACTINELLE, a clinically proven hard vaginal capsule indicated for the prevention and treatment of recurrent vaginal infections of various origins and intensities.

The business model is licensing-and-distribution: Mediner secures marketing authorization for drugs (handled through Hungary's National Centre for Public Health and Pharmacy, NNGYK) and sells them into the Hungarian healthcare system via a wholesale distribution network that complies with applicable pharmaceutical distribution regulations. The company employs between 11 and 50 people and is owned by Hungarian professional investors, with no disclosed venture capital, private equity, or parent-company involvement. The go-to-market is sales-led, centered on targeted marketing to doctors and healthcare professionals in the company's specialty therapeutic areas, leveraging 25 years of continuous operation and relationships with European manufacturing partners. In 2023, the company received the Széchenyi 2023 grant from the Hungarian Government in recognition of its participation in an innovation and R&D support program.

Mediner's operating geography is exclusively Hungary, with no disclosed expansion into other markets. There is no evidence of M&A activity, external funding rounds, leadership changes, or technology platform investments in the input data. The company functions as a focused specialty pharmaceutical distribution operation rather than a technology or growth-equity style venture.

Name

Mediner

Legal name

Mediner Kft.

Website

https://mediner.hu

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Mediner Kft. is a privately held Hungarian pharmaceutical distribution company founded in 2000, specializing in dermatology, pulmonology, and gynecology products licensed from European manufacturers for the Hungarian market.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYHLAIAAAK

Dermatology & Aesthetics Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

• Pharmaceutical distribution
• Drug licensing services
• Dermatology therapeutics
• Pulmonology medicines
• Gynecology products

Headquarters

HQ city

Debrecen

HQ country

Hungary

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Marketing or Sales, Supply Chain, Operations, Personnel, Others

Revenue model

1. Pharmaceutical Distribution: Mediner generates revenue through acquiring drug licenses and distributing pharmaceutical products to the Hungarian healthcare market. Their business model centers on obtaining licenses for drugs from European manufacturers and distributing them through wholesale channels to healthcare providers and patients.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Mediner acquires licenses for pharmaceutical products from European manufacturers and distributes them through compliant wholesale channels to the Hungarian healthcare market, focusing on three specialist therapeutic areas: dermatology, pulmonology, and gynecology. The company handles marketing authorization procedures through the National Centre for Public Health and Pharmacy (NNGYK), executes targeted medical marketing to doctors, and supplies healthcare providers with European-standard medications including its core product LACTINELLE for vaginal infections.

Product overview

Mediner is a pharmaceutical distribution company that markets and distributes drugs in specialist therapeutic areas. The company's core product portfolio includes LACTINELLE, a clinically-proven natural vaginal capsule for treating and preventing vaginal infections. Mediner operates across three main therapeutic areas: dermatology, pulmonology, and gynecology. The company also provides licensing services, marketing, and wholesale distribution, working with Europe's leading pharmaceutical manufacturers to supply Hungarian patients and doctors.

Differentiator

Problem solved

Functional benefit

Brands

• LACTINELLE: LACTINELLE is a hard vaginal capsule product for the prevention and treatment of recurrent vaginal infections of various origins and intensities. Its efficacy is clinically proven.

Products and services

• LACTINELLE LACTINELLE is a hard vaginal capsule used for the prevention and treatment of recurrent vaginal infections of various origins and intensities. It is a natural product with clinically proven effectiveness, intended for patients requiring gynecological therapeutic intervention in Hungary.
• Pharmaceutical Wholesale Distribution Wholesale distribution of licensed pharmaceutical products from European manufacturers to healthcare providers and pharmacies in Hungary, fully compliant with applicable legal regulations for pharmaceutical distribution.
• Drug Marketing Authorization Services Acquisition of drug licenses from European pharmaceutical manufacturers and management of marketing authorization procedures through the National Centre for Public Health and Pharmacy (NNGYK), enabling approved medicines to be brought to the Hungarian market.

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Europe's Leading Pharmaceutical ManufacturerscoreStrategic or Co-development PartnerMediner works closely with Europe's leading pharmaceutical manufacturers to provide the highest quality medications to Hungarian patients and doctors. The company acquires drug licenses from these partners for distribution in the Hungarian market.

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

Regional players

• KRKA: KRKA is a leading Slovenian generic pharmaceutical manufacturer with extensive CEE distribution. Its specialty pharma lines in dermatology, pulmonology, and gynecology make it a regional comparable to Mediner's therapeutic portfolio.
• Zentiva: Zentiva is a major Central European generic pharmaceutical company headquartered in Prague with strong CEE distribution. Its branded and specialty portfolio overlaps with Mediner's therapeutic area focus across the broader CEE region.

Broad incumbents

• PHOENIX Pharma Hungary: PHOENIX Pharma is a pan-European pharmaceutical wholesaler with substantial Hungarian operations. Its full-line wholesale distribution and broad portfolio compete directly with Mediner's Hungarian wholesale business.
• Teva Pharmaceutical Industries: Teva is the world's largest generic pharmaceutical manufacturer with significant Hungarian operations. Its broad portfolio and established Hungarian distribution network make it a major incumbent competitor to Mediner in multiple therapeutic areas.
• Gedeon Richter: Gedeon Richter is Hungary's largest pharmaceutical company with a broad branded generics and specialty pharma portfolio, including significant dermatology and women's health franchises that compete with Mediner's therapeutic focus.

Others

• Bayer Hungary: Bayer operates a Hungarian pharmaceutical division covering dermatology, women's health, and pulmonology. As a major originator manufacturer with Hungarian marketing authorization, Bayer represents both a potential manufacturer partner and indirect competitor to Mediner's distribution model.

Emerging players

• Aramis Pharma: Aramis Pharma is a smaller Hungarian pharmaceutical company focused on specialty and women's health products. Its therapeutic overlap and Hungarian focus make it a relevant emerging comparable to Mediner, particularly for the LACTINELLE franchise.

Direct peers

• EGIS Pharmaceuticals: EGIS is a major Hungarian pharmaceutical manufacturer and distributor headquartered in Budapest. While vertically integrated, EGIS's wholesale distribution arm and CEE-focused branded portfolio closely overlap with Mediner's therapeutic focus areas.
• Goodwill Pharma: Goodwill Pharma is a Hungarian pharmaceutical distribution and licensing company, comparable in size and business model to Mediner: it acquires and distributes specialty pharmaceutical products in the Hungarian market.
• Hungaropharma: Hungaropharma is one of Hungary's largest pharmaceutical wholesale distributors, directly comparable to Mediner's core business of distributing medicines to pharmacies and healthcare providers across Hungary.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/mediner-kft

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mediner